Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Fetoscopic NEOX Cord 1K® Spina Bifida Repair

NCT: NCT04243889 · ACTIVE_NOT_RECRUITING

NCT IDNCT04243889
StatusACTIVE_NOT_RECRUITING
Start Date2020-08-28
Completion2029-03-12
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

To fetoscopically use cryopreserved human umbilical cord allografts, named NEOX Cord 1K®, as a spinal cord cover of spina bifida defects. This procedure will be performed to create a watertight seal covering over the spinal cord in order to decrease the incidence rates of postnatal morbidities. For larger skin defects, NEOX Cord 1K® may be used as a skin cover.

Frequently Asked Questions

What is Fetoscopic NEOX Cord 1K® Spina Bifida Repair?

Fetoscopic NEOX Cord 1K® Spina Bifida Repair is a clinical trial registered under NCT04243889. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04243889?

The current status of NCT04243889 (Fetoscopic NEOX Cord 1K® Spina Bifida Repair) is: ACTIVE_NOT_RECRUITING.

When did Fetoscopic NEOX Cord 1K® Spina Bifida Repair start?

Fetoscopic NEOX Cord 1K® Spina Bifida Repair started on 2020-08-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑